Update shared on 10 Dec 2025
Analysts have nudged their price target on Flotek Industries slightly higher to 19.00 dollars, reflecting modestly lower perceived risk while maintaining essentially unchanged expectations for revenue growth, profit margins, and future valuation multiples.
What's in the News
- Raised 2025 revenue guidance to a range of 220 million to 225 million dollars, up from the prior 200 million to 220 million dollar outlook, signaling stronger expected demand (Key Developments)
- Announced that its XSPCT optical spectrometer is the first optical instrument to meet stringent GPA 2172 and GPA 2261 standards for custody transfer gas measurement, positioning the product as a potential industry benchmark (Key Developments)
- Field trials across major U.S. basins showed XSPCT delivering highly accurate, real-time gas quality and volume data every 5 to 20 seconds with negligible bias versus traditional gas chromatography, highlighting cost and efficiency advantages (Key Developments)
- Reported that both an E&P operator and a midstream company have tested and approved XSPCT for digital valuation of custody transfer, supporting broader customer adoption prospects (Key Developments)
- Added as a constituent to the S&P Global BMI Index, which can enhance visibility among institutional investors and index-tracking funds (Key Developments)
Valuation Changes
- Fair Value: Unchanged at 19.00 dollars per share, indicating a steady central estimate of intrinsic value.
- Discount Rate: Fallen slightly from 7.56 percent to 7.52 percent, reflecting a modest reduction in perceived risk.
- Revenue Growth: Effectively unchanged at approximately 13.30 percent, signaling stable expectations for top line expansion.
- Net Profit Margin: Essentially flat at about 14.56 percent, suggesting no material shift in profitability assumptions.
- Future P/E: Edged down slightly from 15.19x to 15.17x, indicating a marginally lower valuation multiple applied to forward earnings.
Have other thoughts on Flotek Industries?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.